Legal & General Group Plc trimmed its stake in Aflac Incorporated (NYSE:AFL - Free Report) by 19.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 4,218,288 shares of the financial services provider's stock after selling 1,027,141 shares during the quarter. Legal & General Group Plc owned approximately 0.76% of Aflac worth $436,340,000 at the end of the most recent quarter.
A number of other large investors have also made changes to their positions in AFL. EP Wealth Advisors LLC boosted its stake in shares of Aflac by 150.2% during the 3rd quarter. EP Wealth Advisors LLC now owns 14,244 shares of the financial services provider's stock worth $1,593,000 after purchasing an additional 8,552 shares during the last quarter. National Bank of Canada FI boosted its position in Aflac by 22.2% during the third quarter. National Bank of Canada FI now owns 345,803 shares of the financial services provider's stock worth $38,660,000 after acquiring an additional 62,929 shares during the last quarter. iSAM Funds UK Ltd purchased a new stake in Aflac in the 3rd quarter worth approximately $225,000. Zacks Investment Management acquired a new position in Aflac in the 3rd quarter valued at $2,104,000. Finally, Headinvest LLC purchased a new position in shares of Aflac during the 3rd quarter worth $240,000. Institutional investors and hedge funds own 67.44% of the company's stock.
Insider Activity at Aflac
In related news, Director Charles D. Lake II sold 29,802 shares of the stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $107.29, for a total value of $3,197,456.58. Following the completion of the transaction, the director now owns 49,962 shares of the company's stock, valued at approximately $5,360,422.98. This represents a 37.36 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Joseph L. Moskowitz sold 1,000 shares of Aflac stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $107.63, for a total value of $107,630.00. Following the sale, the director now owns 25,393 shares in the company, valued at $2,733,048.59. This represents a 3.79 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.90% of the company's stock.
Aflac Stock Up 2.1 %
Shares of NYSE AFL traded up $2.16 on Friday, hitting $106.84. The company had a trading volume of 2,297,504 shares, compared to its average volume of 2,146,689. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 12-month low of $79.69 and a 12-month high of $115.50. The firm has a market capitalization of $58.31 billion, a P/E ratio of 11.13, a PEG ratio of 3.24 and a beta of 0.81. The business has a 50 day moving average of $106.34 and a two-hundred day moving average of $107.41.
Aflac (NYSE:AFL - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. As a group, equities research analysts forecast that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.
Analyst Ratings Changes
A number of brokerages have recently commented on AFL. BMO Capital Markets began coverage on Aflac in a research report on Thursday, January 23rd. They issued a "market perform" rating and a $111.00 price objective for the company. Piper Sandler upped their price objective on shares of Aflac from $118.00 to $124.00 and gave the company an "overweight" rating in a research note on Wednesday, April 2nd. StockNews.com raised shares of Aflac from a "sell" rating to a "hold" rating in a research report on Friday, February 14th. Barclays dropped their price target on shares of Aflac from $98.00 to $95.00 and set an "underweight" rating for the company in a research report on Friday, February 7th. Finally, Morgan Stanley decreased their price target on shares of Aflac from $105.00 to $100.00 and set an "equal weight" rating on the stock in a report on Thursday. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, Aflac presently has an average rating of "Hold" and a consensus price target of $103.93.
View Our Latest Report on AFL
Aflac Profile
(
Free Report)
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Featured Articles
Before you consider Aflac, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aflac wasn't on the list.
While Aflac currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
